NEW YORK / RankWire.AI / – Global health authorities convened during a UN General Assembly session to advocate for the nation-led deployment of artificial intelligence in disease eradication efforts. This gathering united ministers, public health experts, funders, and diagnostics specialists. The Global Institute for Disease Elimination, also known as GLIDE, co-hosted the event with the RBM Partnership to End Malaria and Nigeria. Key topics included disease monitoring, health system planning, resource distribution, and the prerequisites for responsible AI utilization.
Participants emphasized that governments should steer decisions on how health infrastructures adopt and oversee AI technologies. Michael Adekunle Charles, CEO of the RBM Partnership to End Malaria, spoke on behalf of Nigeria’s health minister, Muhammad Ali Pate. Nigeria’s ongoing Health Sector Renewal Investment Initiative aims to enhance primary healthcare, improve health financing, develop the workforce, and strengthen data systems. The discussion also underscored the importance of integrating emerging technologies with existing national health priorities.
The dialogue explored the essential requirements for broader application of AI across various disease control programs. Reliable data, trained health personnel, sustainable funding, and system integration were highlighted as critical components. Malaria continues to be a primary concern for global health organizations. According to the World Health Organization, there were an estimated 282 million malaria cases worldwide in 2024, resulting in 610,000 deaths. The WHO African Region bore the majority of this burden, with Nigeria recording the highest estimated number of malaria cases.
New AI Initiatives Target Leadership Development in Public Health
GLIDE unveiled two new training programs aimed at enhancing artificial intelligence expertise among public health leaders. Its GLIDE Leadership Excellence in AI for Health initiative will host senior decision-makers in Abu Dhabi from January 17 to 22, 2027. The inaugural residential program will include 25 to 30 participants. Topics covered will include AI governance, organizational preparedness, deployment strategies, and accountability measures. The program specifically targets officials managing health policy and national disease programs.
Mohamed bin Zayed University of Artificial Intelligence collaborated with GLIDE to develop a second initiative, AI for All, designed for public health practitioners. This online course comprises four modules and requires no coding background. It addresses core AI principles, generative AI, bias, data privacy, accountability, and human oversight. The curriculum aims to equip health professionals with the skills to evaluate AI tools within public health contexts and guide organizations in assessing technology before adoption into daily operations.
Partnership Focuses on Technical Collaboration for Malaria Control
During the New York meeting, GLIDE and the RBM Partnership to End Malaria formalized a letter of mutual understanding. This agreement aims to combine technical expertise, innovation, and capacity-building efforts with national malaria priorities. It fosters country-led strategies for malaria prevention and elimination. Additionally, the partnership aligns with the World Health Organization’s Global Technical Strategy for Malaria, which guides international efforts to reduce malaria cases and mortality through 2030, emphasizing surveillance and health system strengthening.
The broader discussion also incorporated topics related to polio and neglected tropical diseases alongside malaria. Attendees reviewed how AI can enhance surveillance, optimize program decisions, and better allocate resources. The event maintained a focus on empowering national health authorities to make informed technology choices. Organizers highlighted the importance of training and institutional capacity building as nations evaluate new digital tools. Overall, the initiatives announced in New York linked AI education, technical cooperation, and national leadership with ongoing efforts to eliminate preventable infectious diseases.